PureHealth Holding PJSC (“PureHealth” or “the Group”) (ADX: PUREHEALTH), the largest healthcare group in the Middle East, announced that shareholders approved a cash dividend of AED 600 million for the financial year ending 31 December 2025 at its Annual General Assembly (AGM) held on 2 April 2026. The approved dividend, equivalent to approximately 30% of net profit, reflects the Group’s strong financial performance and continued commitment to delivering sustainable shareholder returns.
The dividend will be distributed in two equal installments of approximately AED 300 million, on or before 2 May 2026 and 31 August 2026.
In FY2025, PureHealth reported revenue of AED 27.3 billion, up 5.7% year-on-year, while EBITDA increased 16.1% to AED 4.8 billion and net profit rose 17.7% to AED 2.0 billion. The performance was driven by growth across its Healthcare (“Care”) and Insurance (“Cover”) verticals, alongside continued international expansion, including the acquisition of Hellenic Healthcare Group. Approximately 50% of the Group’s asset base is now located outside the UAE, reflecting its evolution into a diversified, international healthcare leader.Shaista Asif, Group Chief Executive Officer of PureHealth, said: “2025 was a year of strong execution for PureHealth, reflecting the strength and scalability of our integrated platform. As we continue to expand globally and advance the use of data and artificial intelligence, we are building a more connected and proactive healthcare system that delivers better patient outcomes and a more proactive approach to health and longevity, while creating long-term value for our shareholders.”
